Business

MeiraGTx receives rare pediatric disease designation from FDA for eye disease treatment

Posted by

[ad_1]

Man having an eye exam at ophthalmologist

dardespot/E+ via Getty Images

  • MeiraGTx Holdings Plc (NASDAQ:MGTX) announced the U.S. Food and Drug Administration has granted the company Rare Pediatric Disease Designation to its AAV8-RK-RetGC program for the treatment of patients with Leber congenital amaurosis due to GUCY2D mutations.
  • Shares of the company

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *